Search Results - "Menter, A" :: K.UTB vyhledávací portál

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

by Papp, K.A., Menter, A., Strober, B., Langley, R.G., Buonanno, M., Wolk, R., Gupta, P., Krishnaswami, S., Tan, H., Harness, J.A.
Published in British journal of dermatology (1951) (01.09.2012)

Get full text

Journal Article

Loading…

Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review

by Sterry, W., Strober, B.E., Menter, A.
Published in British Journal of Dermatology (01.10.2007)

Get full text

Conference Proceeding Journal Article

Loading…

Treatment of two patients with generalized pustular psoriasis with the interleukin‐1β inhibitor gevokizumab

by Mansouri, B., Richards, L., Menter, A.
Published in British journal of dermatology (1951) (01.07.2015)

Get full text

Journal Article

Loading…

No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate‐to‐severe plaque psoriasis

by Strober, B.E., Langley, R.G.B., Menter, A., Magid, M., Porter, B., Fox, T., Safi, J., Papavassilis, C.
Published in British journal of dermatology (1951) (01.02.2018)

Get full text

Journal Article

Loading…

Long‐term efficacy and safety of brodalumab in psoriasis through 120 weeks and after withdrawal and retreatment: subgroup analysis of a randomized phase III trial (AMAGINE‐1)

by Papp, K., Menter, A., Leonardi, C., Soung, J., Weiss, S., Pillai, R., Jacobson, A.
Published in British journal of dermatology (1951) (01.12.2020)

Get full text

Journal Article

Loading…

Efficacy of risankizumab in patients with moderate‐to‐severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa‐1 and UltIMMa‐2 studies

by Strober, B., Menter, A., Leonardi, C., Gordon, K., Lambert, J., Puig, L., Photowala, H., Longcore, M., Zhan, T., Foley, P.
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2020)

Get full text

Journal Article

Loading…

Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

by Menter, A., Papp, K.A., Gooderham, M., Pariser, D.M., Augustin, M., Kerdel, F.A., Fakharzadeh, S., Goyal, K., Calabro, S., Langholff, W., Chavers, S., Naessens, D., Sermon, J., Krueger, G.G.
Published in Journal of the European Academy of Dermatology and Venereology (01.07.2016)

Get full text

Journal Article

Loading…

Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label CADMUS Jr study

by Philipp, S., Menter, A., Nikkels, A.F., Barber, K., Landells, I., Eichenfield, L.F., Song, M., Randazzo, B., Li, S., Hsu, M.‐C., Zhu, Y., DePrimo, S., Paller, A.S.
Published in British journal of dermatology (1951) (01.10.2020)

Get full text

Journal Article Web Resource

Loading…

Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate‐to‐severe plaque psoriasis: results from a randomized phase II study

by Reich, K., Rich, P., Maari, C., Bissonnette, R., Leonardi, C., Menter, A., Igarashi, A., Klekotka, P., Patel, D., Li, J., Tuttle, J., Morgan‐Cox, M., Edson‐Heredia, E., Friedrich, S., Papp, K.
Published in British journal of dermatology (1951) (01.07.2019)

Get full text

Journal Article

Loading…

Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis

by Mamolo, C., Harness, J., Tan, H., Menter, A.
Published in Journal of the European Academy of Dermatology and Venereology (01.02.2014)

Get full text

Journal Article

Loading…

Discordance between physician assessment of psoriasis and patient self-assessment: the importance of itch

by Ryan, C., Menter, A.
Published in British journal of dermatology (1951) (01.07.2016)

Get full text

Journal Article

Loading…

A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis

by Papp, K.A., Menter, M.A., Raman, M., Disch, D., Schlichting, D.E., Gaich, C., Macias, W., Zhang, X., Janes, J.M.
Published in British journal of dermatology (1951) (01.06.2016)

Get full text

Journal Article

Loading…

AB0544 EFFICACY AND SAFETY OF TILDRAKIZUMAB IN PATIENTS WITH AND WITHOUT METABOLIC SYNDROME: 5-YEAR POOLED DATA FROM reSURFACE 1 AND reSURFACE 2

by Gottlieb, A. B., Mehta, N., Menter, A., Mendelsohn, A. M., Rozzo, S., Lebwohl, M.
Published in Annals of the rheumatic diseases (01.06.2021)

Get full text

Journal Article

Loading…

Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)

by Kimball, A.B., Leonardi, C., Stahle, M., Gulliver, W., Chevrier, M., Fakharzadeh, S., Goyal, K., Calabro, S., Langholff, W., Menter, A.
Published in British journal of dermatology (1951) (01.07.2014)

Get full text

Journal Article

Loading…

Efficacy and safety of ixekizumab in a randomized, double‐blinded, placebo‐controlled phase IIIb study of patients with moderate‐to‐severe genital psoriasis

by Ryan, C., Menter, A., Guenther, L., Blauvelt, A., Bissonnette, R., Meeuwis, K., Sullivan, J., Cather, J.C., Yosipovitch, G., Gottlieb, A.B., Merola, J.F., Callis Duffin, K., Fretzin, S., Osuntokun, O.O., Burge, R., Naegeli, A.N., Yang, F.E., Lin, C.‐Y., Todd, K., Potts Bleakman, A.
Published in British journal of dermatology (1951) (01.10.2018)

Get full text

Journal Article

Loading…

Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis and non‐pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER‐1, UNCOVER‐2 and UNCOVER‐3)

by Menter, A., Warren, R.B., Langley, R.G., Merola, J.F., Kerr, L.N., Dennehy, E.B., Shrom, D., Amato, D., Okubo, Y., Reich, K.
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2017)

Get full text

Journal Article

Loading…

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

by Papp, K.A., Menter, M.A., Abe, M., Elewski, B., Feldman, S.R., Gottlieb, A.B., Langley, R., Luger, T., Thaci, D., Buonanno, M., Gupta, P., Proulx, J., Lan, S., Wolk, R.
Published in British journal of dermatology (1951) (01.10.2015)

Get full text

Journal Article

Loading…

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies

by MENTER, Alan, KORMAN, Neil J, VAN VOORHEES, Abby S, BEUTNER, Karl R, BHUSHAN, Reva, ELMETS, Craig A, FELDMAN, Steven R, GELFAND, Joel M, GORDON, Kenneth B, GOTTLIEB, Alice, KOO, John Y. M, LEBWOHL, Mark, LIM, Henry W
Published in Journal of the American Academy of Dermatology (01.04.2009)

Get full text

Journal Article